APCS | Amyloid P component, serum | Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
APPL2 | Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 | Disease related genes
| | | | | Expressed in all |
APRT | Adenine phosphoribosyltransferase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
APTX | Aprataxin | Disease related genes
| | | | | Expressed in all |
AQP2 | Aquaporin 2 (collecting duct) | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
AQP5 | Aquaporin 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AR | Androgen receptor | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Transcription factors
| | | | | Tissue enhanced |
ARFGEF2 | ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) | Disease related genes
| | | | | Expressed in all |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
ARHGEF12 | Rho guanine nucleotide exchange factor (GEF) 12 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ARHGEF9 | Cdc42 guanine nucleotide exchange factor (GEF) 9 | Disease related genes
| | | | | Expressed in all |
ARID1A | AT rich interactive domain 1A (SWI-like) | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ARID1B | AT rich interactive domain 1B (SWI1-like) | Disease related genes Transcription factors
| | | | | Expressed in all |
ARL2BP | ADP-ribosylation factor-like 2 binding protein | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ARMC4 | Armadillo repeat containing 4 | Disease related genes
| | | | | Group enriched |
ARSA | Arylsulfatase A | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ARSB | Arylsulfatase B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ASL | Argininosuccinate lyase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ASNS | Asparagine synthetase (glutamine-hydrolyzing) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ASPA | Aspartoacylase | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ASPSCR1 | Alveolar soft part sarcoma chromosome region, candidate 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
ASXL2 | Additional sex combs like 2 (Drosophila) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ATCAY | Ataxia, cerebellar, Cayman type | Disease related genes
| | | | | Tissue enriched |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
ATM | Ataxia telangiectasia mutated | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATN1 | Atrophin 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Disease related genes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes
| | | | | Tissue enhanced |
ATP7A | ATPase, Cu++ transporting, alpha polypeptide | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATP7B | ATPase, Cu++ transporting, beta polypeptide | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP8B1 | ATPase, aminophospholipid transporter, class I, type 8B, member 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
ATPAF2 | ATP synthase mitochondrial F1 complex assembly factor 2 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |
ATR | Ataxia telangiectasia and Rad3 related | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ATRX | Alpha thalassemia/mental retardation syndrome X-linked | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |